Oral pouch OEM / ODM: define the project before production
PeptideVaultPro supports pouch substrate, filling, container and private-label project development. OEM, ODM, CRO and CDMO routes are assessed against the intended use, technical specification and destination market. Projects begin with a feasibility review rather than a fixed promise of dose, capacity, purity or lead time.

Development scope
- Pouch substrate and dimensions
- Fill formulation compatibility
- Seam and closure evaluation
- Tin or container artwork
- Pilot and commercial project planning
What to include in your brief
Provide composition brief, intended market classification, substrate preference, pouch presentation and container requirements. Identify which parts are fixed and which are open for development. Attach an existing specification or reference sample description when available. State who will approve the formulation, analytical plan and artwork.
Sampling and evaluation
The technical discussion covers material compatibility, fill consistency, pouch integrity, packaging moisture behavior and the project stability plan. A sample plan should identify the questions it needs to answer, acceptance criteria and the records required for the next decision. Changes to the material, process or package should be tracked rather than treated as interchangeable.
Moving toward commercial supply
Validate the pouch and its contents together. Brand names, target claims and destination-market classification must be settled before a production offer. Agree the document set, batch identification, primary and secondary packaging, quotation scope and delivery assumptions in writing. The offered site and certificate scope must match the project.
Choose the support route
OEM
A defined formulation or format with a private-label and packaging brief.
ODM
Joint product-format and formulation development with agreed ownership.
CRO
A defined research work package with methods, deliverables and reporting.
CDMO
Development, pilot work and manufacturing transfer with agreed release criteria.





